A NEW NOSE INHALER.
نویسندگان
چکیده
منابع مشابه
A new multiple dose powder inhaler, (Turbuhaler), compared with a pressurized inhaler in a study of terbutaline in asthmatics.
Twelve adult asthmatic patients participated in an open, randomized, cross-over comparison between cumulatively increasing doses of terbutaline sulphate administered via the multiple dose powder inhaler (Turbuhaler) or via a pressurized inhaler. Turbuhaler and the pressurized inhaler showed equipotency both with respect to bronchodilatation and side effects. Both treatments produced a significa...
متن کاملIs a nose just a nose?
A little over a decade ago, passive humidifiers, ¦^^ commonly called "artificial noses," were rele¬ gated to short-term use, typically less than 24 h. Improvements in design, coupled with careful clini¬ cal investigations, have proven that in select patients, passive humidifiers can be used safely for several days.15 The definition oi several is currently debat¬ able, but evidence for up to 5 d...
متن کاملA Case of Pneumococcal Endocarditis Following a Nose Trauma
Pneumococcal endocarditis is an uncommon disease. Here, we describe a case of endocarditis caused by Streptococcus pneumoniae in a young man following a nose trauma. In traumas that involve the respiratory system and the mucous membrane, bacterial complications such as colonization and bacteremia and end-organ involvement should be considered by physicians.
متن کاملTechnosphere Insulin Inhaler – a Review
Inhaled Insulin is a recent therapeutic advance for the treatment of Diabetes. It offers a convenient, as well as accepted, alternative to injected Insulin. Subcutaneous administration of Insulin results in the pain, inconvenience, and disruption of lifestyle associated with the injection of Insulin, so there has been increasing demand in the development of Aerosolized Insulin. Recent studies s...
متن کاملNew inhaler devices - the good, the bad and the ugly.
Drug delivery to the lungs is an effective way of targeting inhaled therapeutic aerosols and treating obstructive airway diseases, such as asthma and chronic obstructive pulmonary disease (COPD). In the past 10 years, several new drugs for the management of asthma and COPD have been marketed and more are under development. These new therapeutic respiratory drugs have been furthered by innovatio...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: The Lancet
سال: 1883
ISSN: 0140-6736
DOI: 10.1016/s0140-6736(02)24525-0